|
Volumn 23, Issue 3, 2013, Pages 834-838
|
Lead optimization of isocytosine-derived xanthine oxidase inhibitors
|
Author keywords
Docking; Isocytosine; Pharmacokinetics; Structure activity relationship; Xanthine oxidase inhibitors
|
Indexed keywords
ALLOPURINOL;
CYTOSINE;
DOCKING PROTEIN;
FEBUXOSTAT;
ISOCYTOSINE;
UNCLASSIFIED DRUG;
XANTHINE OXIDASE INHIBITOR;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTICLE;
DRUG HALF LIFE;
IC 50;
MOLECULAR DOCKING;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
ADMINISTRATION, ORAL;
ANIMALS;
CATALYTIC DOMAIN;
CYTOSINE;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
INHIBITORY CONCENTRATION 50;
MODELS, ANIMAL;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
RATS;
XANTHINE OXIDASE;
|
EID: 84872280912
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.11.057 Document Type: Article |
Times cited : (32)
|
References (14)
|